Evidence map›Paper›PMID 15296698›Full record

ReviewCurrent atherosclerosis reports2004

Lipoprotein lipase and its role in regulation of plasma lipoproteins and cardiac risk.

Jila Kaberi Otarod, Ira J Goldberg

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current atherosclerosis reports, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Nutrition research and practice · 2018
    Article
  9. Traditional Chinese medicine for lipid metabolism disorders.American journal of translational research · 2017
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. The vascular contribution to Alzheimer's disease.Clinical science (London, England : 1979) · 2010
    Review
  16. Mechanisms of lipase maturation.Clinical lipidology · 2010
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jila Kaberi OtarodDivision of Preventive Medicine & Nutrition, Department of Medicine, Columbia University College of Physicians & Surgeons, 630 West 168th Street, New York, NY 10032, USA. ijg3@columbia.edu
Ira J Goldberg

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For over 50 years, biologists and clinicians have studied lipoprotein lipase (LPL) and learned about its structure, function, cellular production, physiology, and human genetics. LPL is the principal enzyme that removes triglyceride from the bloodstream. It also determines plasma levels of high-density lipoprotein. Surprisingly, within the past several years, a number of new and unexpected proteins have been discovered that regulate the actions of LPL. These include the very low-density lipoprotein receptor, angiopoetin-like protein 3, and apolipoprotein A-V. In addition, mouse genetic studies have confirmed tissue culture findings of nonenzymatic roles of LPL both in lipid metabolism and atherogenesis. These basic observations are now being related to new information on human genetic polymorphism in this gene that is likely to affect clinical evaluation of lipoprotein disorders and cardiac risk.

Indexed as

Angiopoietin-Like Protein 3Angiopoietin-like ProteinsAngiopoietinsApolipoprotein A-VApolipoproteinsApolipoproteins ACardiovascular DiseasesHumansHyperlipoproteinemia Type IIntercellular Signaling Peptides and ProteinsLipoprotein LipaseLipoproteinsAngiopoietin-Like Protein 3Angiopoietin-like ProteinsAngiopoietinsANGPTL3 protein, humanAPOA5 protein, humanApolipoprotein A-VApolipoproteinsApolipoproteins AIntercellular Signaling Peptides and ProteinsLipoprotein LipaseLipoproteins

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.